Li, S. et al. [15] reported MMP11, COL5A2, CDC25B, TOP2A, CENPF, CDCA3, TK1, TPX2, CDCA8, AEBP1, and FOXM1 correlated with clinical prognosis of patients with bladder cancer in 2017. Here, TPX2 is linked to urinary bladder carcinoma.